Abstract
The use of Hypoxis hemerocallidea Fisch. and C.A. Mey. (Hypoxidaceae) extracts for ailments other than benign prostate hyperplasia (BPH) is now a reality. The whole extract, the phytosterols, as well as the major constituents it contains (hypoxoside, and its active derivative rooperol) are now finding new applications in the area of anti-oxidants, anti-inflammatories, anti-diabetics, anti-convulsants, inhibitors of drug marker substances and new evidence is presented of activity against cancerous and premalignant cancer cells. In addition, the over-the-counter (OTC) trade has undergone enormous expansion.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal / pharmacology
-
Anticonvulsants / pharmacology
-
Antineoplastic Agents, Phytogenic / pharmacology
-
Antioxidants / pharmacology
-
Humans
-
Hypoglycemic Agents / pharmacology
-
Hypoxis / chemistry*
-
Male
-
Nonprescription Drugs
-
Phytosterols / chemistry
-
Phytosterols / isolation & purification
-
Phytosterols / pharmacology
-
Phytotherapy*
-
Plant Extracts / pharmacology
-
Plant Extracts / therapeutic use
-
Prostatic Hyperplasia / drug therapy*
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Anticonvulsants
-
Antineoplastic Agents, Phytogenic
-
Antioxidants
-
Hypoglycemic Agents
-
Nonprescription Drugs
-
Phytosterols
-
Plant Extracts